Rats resilient to chronic social stress had higher enkephalin expression in the amygdala, while vulnerable rats showed increased dynorphin in the nucleus accumbens — suggesting these opioid peptides play opposing roles in stress adaptation.
Opposing opioid patternsEnkephalin was lower in vulnerable rats' amygdala while dynorphin was elevated in their nucleus accumbens — suggesting the two peptides have contrasting roles in stress coping
What the researchers found
Enkephalin (ENK) mRNA expression was significantly lower in the basolateral amygdala of stress-vulnerable rats compared to both control and resilient rats, with no difference between resilient and control groups.
Dynorphin (DYN) mRNA was increased in the dorsal and medial shell of the nucleus accumbens only in vulnerable rats compared to controls. In contrast, DYN was increased in the central striatum (caudal part) specifically in resilient rats. Resilience was defined as average defeat latency >350 seconds over seven days of social defeat, while vulnerability was defined as <350 seconds.
Why it matters
Understanding why some individuals are resilient to chronic stress while others develop anxiety, depression, or PTSD-like symptoms is a major challenge in mental health. This study implicates the brain's own opioid peptide systems — which are druggable targets — as key players in stress adaptation, potentially opening new therapeutic avenues for stress-related psychiatric disorders.
How the study worked
Sprague-Dawley rats were subjected to a resident-intruder social defeat paradigm for 7 consecutive days. Based on average latency to assume a subordinate posture, rats were classified as vulnerable (<350 seconds) or resilient (>350 seconds). Rats were euthanized 24 hours after the final stress session. ENK and DYN mRNA expression were measured in specific brain regions including the amygdala, nucleus accumbens, and striatum using in situ hybridization or similar molecular techniques.
What this study cannot tell us
This is a preclinical rat study, and brain region-specific opioid peptide changes may not directly map onto human stress responses. The sample was male-only, so sex differences were not examined. The classification of resilience vs. vulnerability used a single behavioral measure (defeat latency). The study measured mRNA expression, not actual peptide levels, which may not fully reflect functional protein activity.
How to read the evidence
This is a preclinical animal study examining brain region-specific gene expression. It provides mechanistic insights but no clinical evidence or therapeutic intervention testing.
When this study was published
Published in 2013, this study is over a decade old but remains relevant to ongoing research on the neurobiological basis of stress resilience and vulnerability.
The bigger picture
The endogenous opioid system has long been linked to pain, reward, and emotional regulation. This study adds important nuance by showing that two branches of this system — enkephalins and dynorphins — have opposing roles in stress coping. This dual-peptide framework may help explain individual differences in vulnerability to stress-related disorders and could inform development of more targeted therapies that enhance enkephalin signaling or dampen dynorphin activity.
Questions still open
- Would boosting enkephalin signaling in the amygdala promote stress resilience, and could this be achieved pharmacologically?
- Do similar enkephalin/dynorphin expression patterns distinguish stress-resilient from vulnerable individuals in humans?
- How do these opioid peptide changes interact with other stress-response systems like CRF and the HPA axis?
Common questions
What are enkephalins and dynorphins?
Could these findings lead to treatments for stress-related disorders like PTSD?
Read the original research
Enkephalin and dynorphin mRNA expression are associated with resilience or vulnerability to chronic social defeat stress.
Physiology & behavior, 122, 237-45
Citation
Bérubé, Patrick; Laforest, Sylvie; Bhatnagar, Seema; Drolet, Guy. (2013). Enkephalin and dynorphin mRNA expression are associated with resilience or vulnerability to chronic social defeat stress.. Physiology & behavior, 122, 237-45. https://doi.org/10.1016/j.physbeh.2013.04.009